Home/Filings/4/0001214659-19-002033
4//SEC Filing

VANCE JEFFREY 4

Accession 0001214659-19-002033

CIK 0000921582other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 5:00 PM ET

Size

23.0 KB

Accession

0001214659-19-002033

Insider Transaction Report

Form 4
Period: 2019-03-07
Vance Jeff
VP, Finance & Controller
Transactions
  • Sale

    common shares

    2019-03-08$22.43/sh1,436$32,2114,946 total
  • Exercise/Conversion

    restricted share units

    2019-03-077221,589 total
    Exercise: $0.00common shares (722 underlying)
  • Award

    restricted share units

    2019-03-07+5,0025,002 total
    Exercise: $0.00common shares (5,002 underlying)
  • Exercise/Conversion

    common shares

    2019-03-07+7064,581 total
  • Exercise/Conversion

    common shares

    2019-03-07+7225,303 total
  • Exercise/Conversion

    common shares

    2019-03-07+1,0796,382 total
  • Exercise/Conversion

    restricted share units

    2019-03-07706848 total
    Exercise: $0.00common shares (706 underlying)
  • Exercise/Conversion

    restricted share units

    2019-03-071,0794,316 total
    Exercise: $0.00common shares (1,079 underlying)
  • Award

    stock options (to buy)

    2019-03-07$22.49/sh+5,304$119,2875,304 total
    Exercise: $22.49Exp: 2026-03-07common shares (5,304 underlying)
Holdings
  • common shares (opening balance)

    3,875
Footnotes (8)
  • [F1]Represents the conversion upon vesting of restricted share units into common shares.
  • [F2]Mr. Vance is reporting the sale of common shares to satisfy the tax withholding obligations in connection with the delivery of common shares upon conversion of the restricted share unit
  • [F3]Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.
  • [F4]Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.
  • [F5]The restricted share units vest and will be converted to common shares in four installments: 20% of the initial grant on the first anniversary of the grant date, 25% of the initial grant on each of the second and third anniversaries of the grant date and 30% of the initial grant on December 1 of the third year after the grant date.
  • [F6]This represents the number of restricted share units or stock options for this transaction only. Mr. Vance's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 47,714; 11,755 and 4,946 respectively.
  • [F7]The stock options will become exercisable in 4 installments: 1,060 on March 7, 2020; 1,326 on each of March 7, 2021 and March 7, 2022 and 1,592 on March 7, 2023.
  • [F8]The restricted share units vest and will be converted to common shares in four installments 1,000 on March 7, 2020; 1,250 on each of March 7, 2021 and March 7, 2022 and 1,502 on December 1, 2022.

Issuer

IMAX CORP

CIK 0000921582

Entity typeother

Related Parties

1
  • filerCIK 0001382484

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 5:00 PM ET
Size
23.0 KB